Cerity Partners LLC Immunome Inc. Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Immunome Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 53,103 shares of IMNM stock, worth $559,705. This represents 0.0% of its overall portfolio holdings.

Number of Shares

53,103

Previous 48,060 10.49%

Holding current value

$559,705

Previous $581,000 33.56%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$11.7 - $16.51 $59,003 - $83,259	5,043 Added 10.49%	53,103 $776,000
Q2 2024 Aug 13, 2024	SELL	$11.54 - $22.11 $359,621 - $689,013	-31,163 Reduced 39.34%	48,060 $581,000
Q1 2024 May 14, 2024	BUY	$11.01 - $27.34 $196,825 - $488,757	17,877 Added 29.14%	79,223 $1.96 Million
Q4 2023 Jan 26, 2024	BUY	$7.3 - $10.73 $447,825 - $658,242	61,346 New	61,346 $656,000
Q2 2023 Aug 14, 2023	BUY	$4.7 - $7.91 $64,761 - $108,991	13,779 Added 25.83%	67,126 $530,000
Q4 2022 Feb 15, 2023	SELL	$2.21 - $5.0 $7,989 - $18,075	-3,615 Reduced 6.35%	53,347 $117,000
Q2 2022 Aug 10, 2022	SELL	$2.24 - $5.79 $81,948 - $211,821	-36,584 Reduced 39.11%	56,962 $183,000
Q1 2022 Apr 25, 2022	SELL	$3.88 - $13.99 $4,578 - $16,508	-1,180 Reduced 1.25%	93,546 $531,000
Q4 2021 Feb 14, 2022	SELL	$12.96 - $23.44 $94,322 - $170,596	-7,278 Reduced 7.14%	94,726 $1.23 Million
Q3 2021 Oct 25, 2021	SELL	$12.5 - $27.76 $31,062 - $68,983	-2,485 Reduced 2.38%	102,004 $2.48 Million
Q2 2021 Aug 11, 2021	SELL	$16.33 - $32.33 $95,334 - $188,742	-5,838 Reduced 5.29%	104,489 $1.81 Million
Q1 2021 May 12, 2021	SELL	$9.56 - $43.24 $116,813 - $528,349	-12,219 Reduced 9.97%	110,327 $3.74 Million
Q4 2020 Feb 11, 2021	BUY	$9.46 - $14.16 $1.16 Million - $1.74 Million	122,546 New	122,546 $1.19 Million

Others Institutions Holding IMNM

# of Institutions

121

Shares Held

47.1M

Call Options Held

322K

Put Options Held

1.91M

View Full List

About Immunome Inc.

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $128M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

More about IMNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Immunome Inc. Transaction History